JHS Svendgaard Laboratories credit ratios

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
14.814.85.13.60.4
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−4.3−4.3−14.4−6.8−40.5
0.08×0.08×0.03×0.02×0.00×
−0.02×−0.02×−0.08×−0.04×−0.22×
5.66×5.66×−1.28×−3.80×−0.04×
−1.42×−1.64×3.59×7.26×4.45×
−5.68×−5.68×−21.17×−15.83×−15.90×
7.8%7.8%2.9%2.1%0.2%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

JHS₹8.19

JHS Svendgaard Laboratories Limited

· FMCG & Retail
₹ CrorePeersBAJAJCONPGHHMcap ₹71.6 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt0.43.65.114.814.8
Net Debt-40.5-6.8-14.4-4.3-4.3
Total Debt/Equity0.000.020.030.080.08
Net Debt/Equity-0.22-0.04-0.08-0.02-0.02
Total Debt/EBITDA-0.04-3.80-1.285.665.66
Net Debt/EBITDA4.457.263.59-1.64-1.42
Interest Coverage (EBIT/Interest)-15.90-15.83-21.17-5.68-5.68
Total Debt/Total Capital %0.212.052.897.827.82
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.